Health Catalyst Strategy and Business Model

Executive Overview

Health Catalyst is a U.S.-focused healthcare data and analytics company that sells cloud software and professional services to hospitals, health systems, physician groups, and other healthcare organizations. Founded in 2008 and headquartered in South Jordan, Utah, Health Catalyst built its position around a healthcare-specific data platform that integrates clinical, financial, and operational data from electronic health records and other source systems, then layers on analytics applications and domain expertise to help customers improve quality, cost, operations, and revenue-cycle performance. Strategically, the company sits between pure-play software vendors and consulting firms: customers do not just buy dashboards, they buy data infrastructure, workflow tools, and help translating analysis into measurable operational change. Its model is built on recurring technology revenue, supplemented by repeat-driven professional services that support implementation, adoption, and improvement programs. The company’s footprint remains heavily concentrated in the United States, which fits its focus on the complexity of the U.S. provider market. Health Catalyst reported annual revenue of just over $300 million in FY2023, underscoring its status as a specialized rather than broad horizontal software company.

Health Catalyst at a Glance

Logo
Common name	Health Catalyst
Full legal name	Health Catalyst, Inc.
Headquarters	South Jordan, Utah, United States
Ownership	Public company; ownership is primarily institutional and widely held
Ticker	HCAT
Exchange	NASDAQ
Market Cap	$128.95M
Revenue (FY2024)	#N/A
Founding / major historical milestones	Founded in 2008; Nasdaq IPO in 2019; expanded capabilities through acquisitions including KPI Ninja, ARMUS, Twistle, and healthfinch from 2019 to 2021
Industry or industries	Healthcare information technology, healthcare analytics, software-as-a-service, healthcare professional services
Key products or services	Healthcare data platform, analytics applications, quality and performance improvement tools, revenue-cycle software, patient engagement and workflow tools, professional services
Geographic footprint	Primarily United States, with cloud-based delivery and selective international capability
Business segments as officially reported	At the consolidated level, Health Catalyst has operated as a single reportable segment, with revenue disclosed primarily as Technology and Professional Services
Company website	https://www.healthcatalyst.com/

1. What Is the Strategy of Health Catalyst?

1a. What is the winning aspiration of Health Catalyst?

Health Catalyst has long framed its mission as being the catalyst for massive, measurable, data-informed healthcare improvement. In practical strategy terms, winning means becoming a trusted enterprise partner to healthcare providers that need to improve outcomes, lower cost, manage revenue complexity, and operate with better data. This is a more specific aspiration than “selling analytics software.” The company is trying to own an important layer of healthcare decision-making and operational improvement.

Financially, the public message has increasingly paired growth with improving operating discipline. That suggests Health Catalyst’s aspiration is not simply top-line expansion, but scaling recurring technology revenue while moving toward more durable profitability and cash generation.
1b. Where does Health Catalyst play?

Health Catalyst plays primarily in the U.S. healthcare provider market, especially hospitals, health systems, medical groups, and other organizations that manage complex clinical, financial, and operational data. The company focuses on use cases where healthcare-specific data modeling and domain knowledge matter: quality measurement, population health, cost and utilization analytics, revenue-cycle optimization, patient engagement, and workflow improvement.

Its competitive field is therefore narrower than horizontal business intelligence software and broader than a single-function point solution. Health Catalyst tends to play where customers have fragmented data, meaningful financial pressure, and a need for measurable operational change.
1c. How does Health Catalyst plan to win?

Health Catalyst’s core recipe is to combine a healthcare-specific data platform, purpose-built analytics and workflow applications, and professional services that help customers act on the data. That combination is the key differentiator. Many competitors can offer software, and many consulting firms can offer advice, but Health Catalyst’s value proposition is that the software, data model, and improvement expertise are linked.

It also appears to pursue a land-and-expand model. A customer may start with one pressing use case, then add more applications, services, or adjacent modules over time. This approach can create deeper switching costs and a more durable customer relationship than a single-purpose tool sale.
1d. What capabilities must Health Catalyst have in place?

To make that strategy work, Health Catalyst needs several capabilities that are difficult to assemble at once: deep interoperability with healthcare source systems; strong healthcare data engineering; credible domain expertise across clinical, financial, and operational workflows; enterprise selling into provider organizations; and customer success teams that can show measurable return on investment.

It also needs to keep integrating acquired products into a coherent portfolio. In a business like this, weak product integration or inconsistent customer delivery can quickly erode the strategic advantage of a broad platform.
1e. What management systems does Health Catalyst require?

Health Catalyst needs management systems that track both software economics and customer outcomes. On the financial side, recurring technology growth, gross margin mix, operating expense discipline, adjusted profitability, and cash generation matter. On the customer side, implementation speed, adoption, renewal performance, expansion within accounts, and documented operational improvement are critical.

Because the company sells into healthcare, governance around privacy, security, regulatory compliance, and product quality is also central. In effect, Health Catalyst’s management system has to connect product delivery, services execution, and customer value realization rather than managing each function in isolation.

2. What Are the Current Strategic Initiatives of Health Catalyst?

Based on recent annual-report and investor-facing positioning through FY2023 and early 2024, Health Catalyst’s strategic initiatives appear to center on a handful of concrete priorities:

Increase the weight of recurring technology revenue. Management has emphasized technology revenue growth because subscription software carries better gross margins, more visibility, and better long-term scalability than labor-intensive services alone.
Drive cross-sell inside the installed base. Health Catalyst has assembled a wider portfolio over time, including analytics, quality, patient engagement, registry, workflow, and revenue-cycle capabilities. A major initiative is getting more value per enterprise customer rather than relying only on new-logo wins.
Standardize and simplify implementations. Healthcare software can become too custom and services-heavy. Health Catalyst has an incentive to make deployments faster, more repeatable, and less dependent on expensive bespoke work.
Improve profitability and cash generation. Like many mid-cap software companies, Health Catalyst has publicly put more weight on operating discipline, expense control, and moving toward stronger adjusted earnings and cash flow.
Embed more automation and AI into the platform. The company has long marketed healthcare-specific analytics and machine learning. The practical initiative is to make its tools more predictive, more automated, and easier for healthcare users to operationalize.
Stay close to provider pain points. Demand is tied to what healthcare executives are willing to fund: quality reporting, labor productivity, cost control, revenue-cycle pressure, and value-based care. Product and sales priorities therefore tend to follow those operating problems.
Integrate acquisitions into a more coherent platform story. Health Catalyst has bought targeted capabilities. The strategic task is to make the portfolio feel unified to customers rather than a collection of point solutions.

3. What Is the Business Model of Health Catalyst?

Health Catalyst operates a healthcare software-and-services model. Customers buy enterprise data infrastructure, analytics applications, and implementation and improvement support. The company is not selling generic cloud storage or consumer software; it is selling a healthcare-specific system for turning fragmented data into operational action.

What customers actually buy

Access to a healthcare data platform that integrates data from multiple source systems
Applications and tools for analytics, measurement, workflow, and decision support
Professional services to implement the technology, configure use cases, and help realize value

Recurring versus one-time revenue

The technology portion of the model is recurring or contract-based, typically with multi-year characteristics. Professional services are less contractually recurring, but they can be repeat-driven when customers keep expanding programs or need ongoing support. In economic terms, the software layer provides revenue visibility while services help create customer stickiness and drive adoption.

How pricing power works

Health Catalyst’s pricing power appears moderate rather than absolute. The company benefits from switching costs, healthcare-specific know-how, and return-on-investment arguments. However, provider budgets are tight, procurement cycles are long, and customers often compare Health Catalyst with internal analytics teams, EHR-native tools, or lower-cost point solutions.

Why the business mix matters

The mix between Technology and Professional Services is strategically important. More technology revenue generally means higher gross margins, better scalability, and a stronger valuation profile. Services remain important because healthcare customers often need help with implementation and change management, but a services-heavy mix can suppress margins.

What drives margins and cash generation

Gross margin: driven by the mix between software and services, cloud hosting costs, support costs, and services utilization
Operating margin: shaped by sales and marketing spend, research and development investment, and general and administrative costs
Cash generation: supported by subscription collections and a capital-light software model, but affected by working capital needs in services and continued product investment

Revenue model

This is primarily an enterprise subscription and services model. It is not freemium, advertising-driven, or usage-based in the way many consumer or infrastructure software businesses are. The economics depend more on contract value, renewals, expansion, and delivery efficiency.

4. What Products and Services Does Health Catalyst Sell?

Health Catalyst sells a mix of healthcare data-platform capabilities, analytics applications, workflow tools, and professional services.

Healthcare data platform. This is the core layer that ingests, normalizes, and organizes clinical, financial, and operational data from electronic health records and other source systems. It is strategically central because it makes the rest of the application stack possible.
Analytics applications. These tools address use cases such as quality measurement, performance improvement, cost and utilization analysis, operational performance, and population health. They are the products customers see most directly.
Revenue-cycle and financial tools. Health Catalyst has built and acquired software that helps providers with coding, reimbursement, pricing transparency, and related financial workflows.
Patient engagement and workflow automation. Acquired capabilities such as Twistle and healthfinch broadened the portfolio beyond retrospective analytics into workflow execution and patient outreach.
Specialty registries and clinical data assets. Products associated with ARMUS and other healthcare-specific content deepen the company’s position in specialty and quality use cases.
Professional services. These include implementation, analytics support, improvement services, and advisory-style work that helps customers adopt the software and achieve measurable results.

The most strategically important offerings are the recurring technology products built on the core data platform. Professional services are also important, but more as an adoption engine and relationship extender than as the ultimate economic destination of the model.

5. What Are the Key Competitors or Peers of Health Catalyst?

Health Catalyst competes in a fragmented market. Some rivals are direct healthcare analytics platforms, while others are substitutes embedded in broader healthcare IT or consulting ecosystems.

Innovaccer — A healthcare data-platform and population-health company that competes in interoperability, analytics, and value-based care workflows.
Arcadia — Focused on healthcare data aggregation and analytics, especially for value-based care and risk-bearing provider organizations.
MedeAnalytics — A long-standing healthcare analytics vendor serving providers and payers with financial, operational, and clinical analytics.
Premier — Better known for group purchasing, but also active in provider performance improvement, benchmarking, and analytics through its PINC AI offerings.
Syntellis Performance Solutions — Competes more directly in provider finance, performance management, planning, and decision support.
Optum Insight — A much larger health-services and analytics competitor that can bundle software, data, and consulting-like services at enterprise scale.
Oracle Health — Through the Cerner business and related products, Oracle can offer embedded analytics and workflow tools that reduce the need for third-party layers in some accounts.
Epic Systems — Epic is primarily an electronic health record vendor, but its reporting, population-health, and analytics tools can function as in-house substitutes for some Health Catalyst use cases.
Clarify Health Solutions — Uses healthcare data and analytics to help customers benchmark cost and performance; not identical, but adjacent in provider decision-support.
Inovalon — More payer-oriented in some areas, but relevant in quality, data, and measurement workflows that overlap with parts of Health Catalyst’s offering.

The most important competitive pressure often comes from three directions at once: healthcare-specific analytics vendors, large diversified health-tech firms, and customers deciding that their EHR-native tools are “good enough.”

6. What Is the Marketing Strategy of Health Catalyst?

Health Catalyst’s marketing is best understood as enterprise thought-leadership and evidence-based demand generation rather than mass-market brand advertising. The company sells to senior healthcare executives who care about measurable outcomes, referenceable results, and implementation credibility.

Thought leadership: Healthcare improvement content, benchmarking, webinars, conferences, and executive education help position Health Catalyst as a domain expert, not just a software seller.
Proof-based marketing: Case studies and documented operational or clinical improvements are important because healthcare buyers often require evidence before funding a platform decision.
Account-based and field marketing: Because deal sizes are meaningful and sales cycles are long, marketing likely works closely with enterprise sales on named accounts, buying committees, and executive stakeholders.
Partner and ecosystem marketing: Relationships in the healthcare IT ecosystem can support credibility, particularly where interoperability and implementation matter.

Marketing appears to be a supporting capability rather than the company’s primary differentiator. The real differentiation is product-market fit in healthcare workflows and the ability to show outcomes. Marketing’s role is to make that credibility visible to buyers.

7. What Are the Key Customer Segments of Health Catalyst?

Health Catalyst’s customer base is concentrated in healthcare delivery organizations rather than spread broadly across all industries.

Hospitals and health systems — The core segment, especially organizations with large, fragmented data environments and pressure to improve quality, cost, and operations.
Physician groups and ambulatory networks — Relevant where organizations need analytics, workflow tools, or value-based care support across outpatient settings.
Risk-bearing and value-based care organizations — Including organizations that need population health, measurement, and cost management capabilities.
Clinical and specialty programs — Specialty registries and service lines can require more tailored measurement and benchmarking tools.
Adjacent healthcare organizations — In some cases, Health Catalyst can address needs for payers or other healthcare stakeholders, but the provider side appears most central.

The most important buyer groups inside customer organizations are usually not just one function. They can include chief information officers, chief financial officers, chief medical officers, quality leaders, population-health leaders, and revenue-cycle executives. That makes the sale complex but also creates room for multi-department expansion once the platform is established.

8. What Is the Sales Model of Health Catalyst?

Health Catalyst uses a direct, consultative enterprise sales model. It sells primarily through its own sales force rather than through retail channels or broad distributor networks.

Direct enterprise selling: Deals often involve multiple stakeholders and long evaluation periods because the products touch core healthcare data and operating workflows.
Land-and-expand motion: An initial sale may center on one high-priority problem, such as quality measurement or revenue-cycle improvement, then expand into additional modules or services.
Software-plus-services selling: The sales motion often includes both technology and implementation support, which can increase close rates but also makes solution design more complex.
Reference-driven selling: Existing customer outcomes matter in healthcare. Peer references and demonstrated ROI are likely important components of the go-to-market model.
Selective ecosystem leverage: Channel effects can come through healthcare IT partners and industry relationships, but the core sales responsibility remains internal.

This structure affects growth in predictable ways: it supports deeper customer intimacy and larger contracts, but it also means longer sales cycles and a heavier need for sales productivity, account prioritization, and post-sale expansion discipline. That is one reason consultant support is often more relevant in sales effectiveness and segmentation than in basic channel management.

9. In What Geographies Does Health Catalyst Operate?

Health Catalyst is primarily a United States business. Its software and services are geared to the data structures, reimbursement models, and workflow complexity of the U.S. healthcare system, and that is where the overwhelming strategic focus appears to be.

Operationally, the company is headquartered in South Jordan, Utah, and uses a software-and-services delivery model rather than a plant or physical distribution network. That means geographic reach depends more on sales coverage, implementation capacity, cloud delivery, and healthcare-market expertise than on factories or warehouses.

The company can support customers beyond a single local market, and some acquired capabilities may have broader applicability, but Health Catalyst is best understood as a nationally scaled U.S. healthcare IT company rather than a broadly global software platform.

10. Who Are the Owners of Health Catalyst?

Health Catalyst is a publicly traded company on Nasdaq under the ticker HCAT. Ownership is widely held and primarily institutional. Based on public filings around 2024, large shareholders have included major asset managers such as Vanguard and BlackRock, along with smaller investment firms active in healthcare and growth equities. Founder, executive, and director ownership has remained meaningful, but no single shareholder appears to hold a controlling stake.

11. How Is Health Catalyst Organized?

At the reporting level, Health Catalyst has operated as one reportable segment, which is common for software companies that manage the business on a consolidated basis. That said, the company is easier to understand operationally through three practical lenses:

Technology platform and applications — The software products, data platform, and acquired tools that make up the core commercial offering
Professional Services — Teams that implement products, support customers, and help drive measurable improvement
Corporate functions — Sales, marketing, finance, legal, and administrative support functions

Management also has to integrate products that entered through acquisitions, which means the practical organization likely balances functional leadership with product-family ownership. The key distinction is that formal external reporting may look simpler than the internal reality of managing a portfolio of healthcare software and service capabilities.

12. How Does Health Catalyst Operate?

Health Catalyst’s day-to-day operating model revolves around turning messy healthcare data into usable insight and workflow support.

Connect and ingest data. The company integrates data from electronic health records, financial systems, operational systems, and other healthcare data sources.
Normalize and organize the data. Healthcare data is difficult because source systems use different formats, definitions, and levels of quality. This data-engineering step is a core value-creation activity.
Deploy software applications and content. Once the data layer is working, customers can use analytics applications, measurement tools, workflow products, or specialized solutions.
Support implementation and adoption. Professional services teams help customers configure the software, identify priority use cases, and build operating routines around the data.
Expand and retain the account. If the customer sees value, Health Catalyst can add more products, use cases, or services over time.

The operating bottlenecks are typical of healthcare IT: data quality issues, long implementation cycles, change management inside provider organizations, integration complexity, and the need to prove financial and clinical value. Success therefore depends as much on execution and customer adoption as on the underlying software.

13. What Are the Growth Opportunities for Health Catalyst?

The most plausible growth opportunities for Health Catalyst come from deepening its role inside existing customer accounts and improving the economics of what it already does well.

Cross-sell and expansion within the installed base. A broader product portfolio creates room to sell additional analytics, workflow, quality, or revenue-cycle products into existing provider customers.
Shift toward higher-margin technology revenue. Standardizing deployments and reducing unnecessary service intensity could improve both growth quality and margins.
AI-enabled workflows and decision support. If Health Catalyst can make analytics easier to use and more predictive, it can increase product relevance without requiring proportionate service labor.
Revenue-cycle and financial improvement products. Provider financial pressure remains high, which can support demand for software that helps with reimbursement, coding, and operational efficiency.
Broader penetration of mid-sized provider organizations. More packaged and repeatable offerings may open parts of the market that are harder to serve with heavily customized enterprise deployments.
Selective adjacent-market expansion. There may be room in payer, employer, or life-sciences-adjacent use cases, but those moves would likely require careful focus to avoid diluting the core provider proposition.
Partnership-led distribution. Stronger ecosystem relationships could help sourcing and implementation in a market where trust and interoperability matter.

The main constraints are also clear: provider budget pressure, competition from EHR-native tools, long enterprise sales cycles, implementation complexity, and the challenge of integrating a broad product portfolio into a simple customer message.

14. What Is the History of Health Catalyst?

Health Catalyst was founded in 2008 in Utah by healthcare analytics entrepreneurs including Dan Burton and Steve Barlow. The company emerged during a period when U.S. providers were investing more heavily in data infrastructure, quality measurement, and operational improvement.

2008: Founded to address healthcare improvement through better data and analytics.
2010s: Built out its healthcare data platform and professional-services-led model, helping establish a position with health systems that needed more than basic business intelligence tools.
2019: Went public on Nasdaq under the ticker HCAT, giving the company additional capital and visibility.
2019 to 2021: Used acquisitions to broaden the product portfolio, including analytics, registry, patient engagement, and workflow capabilities.
2022 onward: Strategy shifted more visibly toward balancing growth with improved profitability and cash discipline, a pattern seen across much of the software sector.

Health Catalyst’s history is notable less for dramatic restructuring and more for a steady evolution from a healthcare analytics specialist into a broader software-and-services platform focused on measurable provider improvement.

15. What Are the Key Suppliers to Health Catalyst?

Health Catalyst is a software company, so its key suppliers are technology and data ecosystem partners rather than raw-material vendors. The strategically important supplier categories are:

Cloud infrastructure providers — Hosting, computing, storage, and related platform services that support the delivery of software products
Cybersecurity and enterprise software vendors — Tools that help with identity, monitoring, development, and secure operations
Interoperability and health IT ecosystem dependencies — Access to data from electronic health records and other healthcare systems is essential to the product’s usefulness
Third-party data and content sources — In some use cases, benchmarking, coding, quality, or other external content can matter
Specialized service partners — Select technical or implementation partners may be used where customer delivery requires extra capacity or niche expertise

Supplier structure matters strategically because service reliability, security, and data access directly affect product performance. The bigger issue is less physical supply risk and more dependence on the broader healthcare IT ecosystem, especially the ability to integrate cleanly with major source systems.

16. How Is Health Catalyst Using AI?

Health Catalyst has publicly positioned artificial intelligence and machine learning as embedded capabilities inside a healthcare data and analytics platform rather than as a standalone AI business. The company has a long history of talking about augmented intelligence in healthcare, meaning software that helps clinicians and administrators make better decisions rather than replacing them.

Established use cases: predictive analytics, risk stratification, prioritization, and other model-driven workflows that sit on top of integrated healthcare data
Workflow automation: patient engagement and operational products can use data-driven rules or models to trigger communications and next-best actions
Healthcare-specific model development: public materials over time have highlighted healthcare-tailored machine learning, including the company’s open-source Healthcare.AI work
More recent direction: management has discussed making analytics easier to access and more automated, which implies continued AI expansion, but that should be understood as product evolution rather than a completed transformation

The important point is that Health Catalyst’s AI strategy is most credible when tied to concrete healthcare workflows, not generic AI branding.

17. What Is the Technology Strategy of Health Catalyst?

Technology is central to Health Catalyst’s competitiveness. The company’s strategy is to provide a healthcare-specific data and application layer that sits above fragmented provider systems and turns those systems into actionable intelligence.

Interoperability first: the platform has to connect to electronic health records, financial systems, and operational systems across a customer environment
Data normalization and governance: a core technology task is turning inconsistent healthcare data into a reusable, trusted asset
Cloud-based delivery: the model benefits from scalable cloud infrastructure rather than on-premise software as the primary architecture
Reusable applications on top of the data layer: the strategic goal is not just integration, but monetizing that integration through higher-value products
Security and compliance: privacy, access control, auditability, and healthcare-grade reliability are essential, not optional
Portfolio integration: acquired technologies need to work together coherently to avoid customer friction and excessive implementation cost

This is a case where technology is both an internal enabler and part of the customer offering. Health Catalyst is selling its technology stack directly, but the way it engineers interoperability, security, and scale also determines whether the business model works at all.

18. What Is the R&D Strategy of Health Catalyst?

Research and development is important for Health Catalyst because healthcare analytics software does not stay useful unless the company keeps improving data models, integrations, user workflows, and clinical or financial content. The company’s R&D priorities appear to center on making the platform more scalable, the applications more healthcare-specific, and the acquired portfolio more integrated.

Platform enhancement: improving the underlying data architecture, interoperability, performance, and ease of deployment
Application innovation: adding or refining use cases in quality, population health, finance, revenue cycle, and operations
Automation and AI: embedding more model-driven logic and workflow support in products
Portfolio integration: ensuring that acquired products do not remain isolated point solutions
Healthcare-specific content: continuing to invest in the domain knowledge and rules that make the products usable in real provider settings

For Health Catalyst, R&D is less about frontier science and more about making complex healthcare data usable, repeatable, and valuable at enterprise scale.

19. What Is the Finance Strategy of Health Catalyst?

Health Catalyst’s finance strategy appears built around a familiar software-company tradeoff: invest enough in product and go-to-market to grow recurring revenue, while improving the efficiency of the model so growth translates into better margins and cash flow.

Recurring revenue emphasis: technology revenue is strategically attractive because it is higher margin and more scalable than services
Expense discipline: more recent public messaging has emphasized tighter operating control and a more durable path to profitability
Selective reinvestment: capital is most likely to go toward product development, sales capacity, and integration of acquired capabilities rather than asset-heavy expansion
Cash generation: improving collections, software mix, and delivery efficiency all matter because the model is more attractive when it can fund growth with less external dependence
M&A discipline: acquisitions can add capabilities, but the finance logic only works if integration is disciplined and the deals strengthen recurring economics

In short, Health Catalyst’s finance strategy supports its broader corporate strategy by trying to turn a healthcare-specific growth story into a more efficient software platform with better operating leverage.

20. What Major Acquisitions Has Health Catalyst Made?

Acquisitions have played a meaningful but targeted role in Health Catalyst’s development. The company has not behaved like a pure roll-up; instead, it has used M&A to add specific capabilities around analytics, workflow, and healthcare content.

KPI Ninja (2019) — Added analytics and interoperability-related capabilities that fit the company’s provider data-platform strategy.
Able Health (2020) — Expanded quality measurement and reporting capabilities.
ARMUS (2020) — Strengthened specialty registry and clinical data capabilities, particularly valuable in specialty care and benchmarking contexts.
Twistle (2021) — Added patient engagement and communication workflow capabilities, helping extend Health Catalyst beyond analytics into action-oriented workflow.
healthfinch (2021) — Added clinical workflow automation capabilities, broadening the platform’s operational relevance inside provider organizations.

The strategic logic behind these deals was capability expansion: make the platform more useful across more provider workflows, increase cross-sell potential, and create more ways to monetize the customer relationship. The main risk, as with any portfolio strategy, is integration complexity.

21. How Companies Like Health Catalyst Leverage Independent Consultants through Umbrex

Companies like Health Catalyst engage Umbrex when they need talent with the training of top-tier consulting firms but do not need a full consulting team with all the overhead. Umbrex has grown a global community of over 8,000 independent management consultants based in more than 50 countries. These consultants are alumni of McKinsey, Bain, BCG, and other leading firms, with expertise across Strategy, Operations, Organization, Marketing, Sales, Finance, Technology, ERP, and AI. For a company like Health Catalyst, the best uses are usually tightly scoped, high-value projects tied to growth, product strategy, profitability, and execution.

Refine segment strategy across large health systems, mid-sized providers, value-based care organizations, and adjacent markets
Redesign pricing and packaging for platform subscriptions, point applications, and professional services bundles
Build a land-and-expand playbook to increase cross-sell across analytics, revenue-cycle, workflow, and patient-engagement products
Assess which AI use cases are most commercially valuable and operationally feasible in provider workflows
Rationalize the acquired product portfolio and create a clearer integration roadmap across legacy and acquired offerings
Improve professional-services utilization, delivery margin, and implementation standardization
Upgrade enterprise sales effectiveness, account prioritization, and account-based marketing for multi-stakeholder healthcare deals
Design a partner strategy covering electronic health record ecosystems, cloud providers, and implementation partners
Develop a profitability improvement program linking gross margin mix, operating leverage, and cash-generation priorities
Support product-management and R&D governance so investment is concentrated on the highest-return platform and application initiatives